Sign in to continue:

Sunday, July 26th, 2026

Freedom Holding Corp. (FRHC) 2026 10-K Report: Business Segments, Geographic Operations, and Financial Disclosures

Freedom Holding Corp. FY2026 Annual Report: Key Highlights for Investors

Freedom Holding Corp. FY2026 Annual Report: Key Highlights for Investors

Executive Summary

Freedom Holding Corp. (FRHC) has released its annual 10-K report for the fiscal year ended March 31, 2026. The company, based in New York and operating under the Security Brokers, Dealers & Flotation Companies classification, continues its evolution as a dynamic financial services provider with growing exposure to banking, insurance, and crypto assets.

Key Points and Price-Sensitive Developments

1. Diversification and Segment Expansion

  • Segmental Growth: FRHC’s operations now span brokerage, banking, insurance, and other financial services segments, as highlighted by the existence of distinct reporting for these units. The company is no longer solely dependent on brokerage, with banking and insurance emerging as significant contributors to overall performance.
  • Geographical Presence: The company reports activities in major financial jurisdictions including the US, Germany, Cyprus, Turkey, the UK, and the UAE. This diversification provides resilience against localized economic risks and exposure to high-growth regions.

2. Strategic Acquisitions and Disposals

  • Acquisitions: The report references notable business acquisitions, including entities such as Arbuz Group LLP, ReKassa, ITSTech Limited, and Astel Group Ltd. Notably, there is mention of a “Series of Individually Immaterial Business Acquisitions,” which indicates a strategy of multiple bolt-on acquisitions to drive incremental growth and market share.
  • Disposals & Discontinued Operations: There are disclosures relating to disposal groups, including discontinued operations in entities like Comrun LLP and Freedom UA, which could indicate ongoing business optimization or a shift in strategic focus.

3. Asset and Investment Management

  • Substantial Holdings in Financial Instruments: FRHC’s balance sheet contains a diverse range of financial instruments, including US sovereign debt, non-US sovereign debt, corporate debt securities, corporate equity, and exchange-traded notes. The fair value disclosures indicate active management and potential exposure to market volatility.
  • Fair Value Hierarchy: The company’s assets are measured across all levels of the fair value hierarchy (Levels 1, 2, and 3), with a notable portion in Level 3 (less liquid, harder-to-value assets), particularly in corporate equity and debt instruments. This may increase earnings volatility and risk, but also offers the prospect of higher returns.
  • Repurchase Agreements & Term Deposits: The report details active use of repurchase agreements and term deposits for liquidity and yield management, with maturities ranging from up to 30 days to 90 days.

4. Credit and Receivables Quality

  • Loan Book Composition: The portfolio includes corporate loans and other loans, with explicit disclosure about credit quality, such as loans “with significant increase in credit risk” and “not credit impaired.” This transparency is important for assessing asset quality and the potential for future impairments.
  • Receivables Aging: FRHC provides detail on receivables past due, including those over 90 days, indicating a robust risk management approach and giving investors insight into credit exposure.

5. Customer and Concentration Risks

  • Customer Concentration: There is explicit reporting on customer concentration risk, including major accounts and related parties, which can influence revenue stability and regulatory risk.

6. Intangible Assets and Technology

  • Intellectual Property and Intangible Assets: The company holds significant intangible assets, including advances paid for future technology or business development, which may translate into future growth but also carries execution risk.

What Shareholders Must Know

  • FRHC’s strategic expansion into banking and insurance is likely to diversify revenue streams and reduce reliance on brokerage alone. This could be a catalyst for long-term share price appreciation if executed successfully.
  • The company’s aggressive M&A activity, especially the acquisition of Arbuz Group LLP and others, signals a growth strategy but could involve integration risks and impact earnings in the short term.
  • Exposure to Level 3 assets introduces valuation uncertainty. Significant swings in fair value, especially in illiquid instruments, could have a material impact on quarterly results and, by extension, the share price.
  • Disposal of non-core or underperforming assets (e.g., discontinued operations) may streamline the business and enhance profitability, which would be positively received by the market.
  • Shareholders should monitor customer and counterparty concentration risks, as a significant event affecting a major account could materially impact financials.
  • The company’s presence in multiple jurisdictions provides both risk diversification and exposure to foreign regulatory environments. Any geopolitical or regulatory changes in these regions could significantly affect operations.

Potential Share Price Movers

  • Successful integration of acquisitions and realization of synergies could deliver upside surprises to earnings.
  • Any impairments or adverse movements in Level 3 asset valuations could negatively affect results and investor sentiment.
  • Regulatory changes or economic shocks in major markets (US, Germany, Cyprus, Turkey, UK, UAE) could have outsized impacts due to the company’s geographical footprint.
  • Further expansion into crypto assets (as noted in the company’s SIC classification) could drive both growth and volatility, depending on market conditions.

Conclusion

Freedom Holding Corp.’s FY2026 10-K report reveals a company in transition, aggressively diversifying its business and asset base, and expanding across geographies and segments. While these moves open the door to higher growth and profitability, they also introduce complexity and risk. Investors should pay close attention to acquisition integration, asset quality (especially Level 3 fair value assets), and regulatory developments across the company’s markets.


Disclaimer: This article is a summary and analysis for informational purposes only and does not constitute investment advice. Investors should refer to the full 10-K filing and consult with their financial advisors before making investment decisions. Past performance is not indicative of future results.


View Freedom Holding Corp. Historical chart here



Tenaya Therapeutics: Advancing Genetic Medicines and Small Molecule Therapies for Heart Disease Treatment

Tenaya Therapeutics, Inc. 2025 Annual Report – Investor Anal...

Rockwell Medical, Inc. Reports Q4 and Full-Year 2025 Financial Results and Operational Highlights

Rockwell Medical Announces Fourth Quarter and Full-Year 2025...

Kennametal Inc. Completes $300 Million Offering of 5.800% Senior Notes Due 2036

Kennametal Inc. Issues \$300 Million Senior Notes – Key Inve...